Tissue acid and alkaline phosphatase in prostatic carcinoma

Area of Science:

• Biochemistry
• Urology
• Oncology

Background:

• Infravesical obstruction is a common condition requiring diagnostic differentiation.
• Prostatic carcinoma and benign prostatic hyperplasia (BPH) present with similar symptoms.
• Accurate biochemical markers are needed for distinguishing between these conditions.

Purpose of the Study:

• To investigate the enzymatic differences in prostatic tissues between malignant carcinoma and BPH.
• To evaluate the utility of acid phosphatase and alkaline phosphatase as potential biomarkers.

Main Methods:

• Tissue specimens from 28 patients (14 with prostatic carcinoma, 14 with BPH) were analyzed.
• Enzymatic activity of total and tartarate-labile acid phosphatase, and alkaline phosphatase was measured using a fluorimetric method.
• Inhibition levels with L(+) tartarate were assessed.

Main Results:

• Enzyme levels showed a trend favoring malignant tissue, but this was not statistically significant.
• Distinct inhibition patterns were observed between benign and malignant tissues upon L(+) tartarate addition.
• Alkaline phosphatase levels were lower than acid phosphatase and showed no significant difference between the groups.

Conclusions:

• Current enzymatic assays for acid and alkaline phosphatase, including tartrate inhibition, do not reliably differentiate between benign and malignant prostatic tissue in this cohort.
• Further research with larger sample sizes or novel biomarkers is warranted for improved diagnostic accuracy.